progression-free
59 results
1 - 59- progression-free
- progression-free survival
- PFS
- acalabrutinib
- mogamulizumab
- dacomitinib
- isatuximab
- tucatinib
- lenalidomide
- lutetium lu 177 dotatate
- tivozanib
- olaparib
- trabectedin
- cabozantinib
- trametinib
- avelumab
- gefitinib
- lanreotide
- encorafenib
- radical
- obinutuzumab
- brigatinib
- abatacept
- ado-trastuzumab
- palbociclib
- idelalisib
- lenvatinib
- durvalumab
- riTUXimab
- afatinib
- everolimus
- PAZOPanib
- panobinostat
- dabrafenib
- Triiodothyronine, Total and Free
- Prostate-Specific Antigen
- Hyperlipoproteinemia
- Osteoporosis
- Albumin and Albumin/Globulin Ratio
- Delta-Aminolevulinic Acid
- Cancer Markers
- Prostate Cancer
- Ultrasound Studies, Various Sites(Abdomen, Bladder, Breast, Pelvis, Prostate, Scrotum, Thyroid and Parathyroid Glands)
- Bioterrorism and Public Health Safety Concerns: Testing for Toxins and Infectious Agents